As of 12:30 PM on the 10th, Celltrion is trading at 328,500 KRW, up 0.15% from the previous day. This represents a 13.89% decline compared to January 13. Celltrion is known as a manufacturer of protein and biopharmaceutical products.

Today, foreigners are tentatively recorded as net sellers of 6,000 shares of Celltrion, while institutions are net sellers of 9,000 shares. Over the past five days, individual investors have net purchased 586,387 shares, whereas foreigners and institutions have net sold 231,538 shares and 362,832 shares, respectively.


On February 8, Celltrion was a market topic with the headline "Strong performance following MFDS approval of COVID-19 antibody treatment."





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing